Tag: Prescription Drugs

Overall survival longer with cemiplimab versus single-agent chemo for recurrent disease after first-line platinum-containing chemo

Adverse events common during first year of methotrexate therapy for early rheumatoid arthritis, but most not serious

Median progression-free survival significantly prolonged with trametinib versus one of five standard-of-care treatment options

Switching to dry powder inhaler more than halves carbon footprint of asthma treatment without asthma worsening

Rate of symptomatic intracranial hemorrhage lower with tenecteplase than the current standard medication for thrombolysis, alteplase

50-mg dose shows significant improvement versus placebo for sleep onset, sleep maintenance, and total sleep time

63.0 percent of patients reached full remission at day three; remission remained high at 69.5 percent at week six

Significantly lower rates of initiation seen in Black and American Indian or Alaskan Native individuals

No difference seen for in-hospital mortality, but need for initiation of mechanical ventilation reduced with addition of remdesivir to standard care

Polygenic score based on single nucleotide polymorphisms in the ara-C pathway genes may predict treatment outcomes